NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I agree. It's all speculation and lottos variables and issues to consider right now including the markets and state of the world. But hoping and anticipating ultimately higher market caps. Juno was $4-6 billion, and higher when it was still in trials. They had fierce competition, patents were subject to dispute, they were making it by hand, cost $1 million at that time, and it was only for blood cancer which, as I said, there was fierce competition... AND patients died from the treatment, and ultimately recurrence is a big issue with car-t. It is a great and powerful scalpel, but not necessarily a cure for everyone.

I am optimistic that DCVax will be a huge addition to the immunotherapy tool box across the board to many cancers and will be seen as such by other companies looking for combination therapies to make their own drugs more relevant. Not sure how fast that will happen. With very low to easy side-effects if any, and a profile that literally trains the immune system to know that cancer, I am optimistic. They need to get off the OTC, ultimately, and the market needs to better understand the product and what it does.